Ruiping Zhai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ruiping Zhai has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Bin Wu
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
39 shared publications - Changming Zhou
Department of Respiratory Disease, The First Affiliated Hospital of Bengbu Medical College , Bengbu , China
39 shared publications - Chaosu Hu
Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
39 shared publications - Dan Ou
Department of Radiation Oncology Fudan University Shanghai Cancer Center Shanghai China
39 shared publications - Dongmei Ji
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
39 shared publications - Hongmei Ying
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Fudan University Shanghai Cancer Center, Shanghai, China
39 shared publications
Latest Publications
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
The Differential Expression of Various Genes between the Resistant and Sensitive Groups
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
The Differential Expression of Various Genes between the Resistant and Sensitive Groups
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Details of radiotherapy (N=27)
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Details of radiotherapy (N=27)
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Details of radiotherapy (N=27)
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Details of radiotherapy (N=27)
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Comparative Analysis of Peripheral Lymphocyte Subpopulations Before Treatment in the Sensitive and Resistant Groups
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Comparative Analysis of Peripheral Lymphocyte Subpopulations Before Treatment in the Sensitive and Resistant Groups
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Overall response rate of induction chemoimmunotherapy (N=27)
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Overall response rate of induction chemoimmunotherapy (N=27)
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Changes of quality of life at different timepoints
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Changes of quality of life at different timepoints
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Comparative Analysis of Peripheral Lymphocyte Subpopulations Before Treatment in the Sensitive and Resistant Groups
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Comparative Analysis of Peripheral Lymphocyte Subpopulations Before Treatment in the Sensitive and Resistant Groups
- Open Access
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Recurrence patterns and reasons for death (N=27)
- 17 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Recurrence patterns and reasons for death (N=27)